Privately held Marathon Pharmaceuticals LLC has submitted a New Drug Application to the FDA for Deflazacort, an investigational Duchenne Muscular Dystrophy drug.
Forex – financial instrument.Forex news
Privately held Marathon Pharmaceuticals LLC has submitted a New Drug Application to the FDA for Deflazacort, an investigational Duchenne Muscular Dystrophy drug.